Julien Taurelle

467 total citations
9 papers, 384 citations indexed

About

Julien Taurelle is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Julien Taurelle has authored 9 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Julien Taurelle's work include Sarcoma Diagnosis and Treatment (3 papers), Bone health and treatments (3 papers) and Cell death mechanisms and regulation (2 papers). Julien Taurelle is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), Bone health and treatments (3 papers) and Cell death mechanisms and regulation (2 papers). Julien Taurelle collaborates with scholars based in France, Italy and Sweden. Julien Taurelle's co-authors include Dominique Heymann, Françoise Rédiní, Julie Chesneau, Christophe Breton, Claude Remacle, Jörg Tost, Claudine Junien, Tomas J. Ekström, Jean Lésage and Anne Gabory and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Julien Taurelle

9 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julien Taurelle France 7 178 155 84 83 76 9 384
Ana Katušić Bojanac Croatia 12 307 1.7× 96 0.6× 30 0.4× 65 0.8× 40 0.5× 54 470
Akihito Horie Japan 13 99 0.6× 110 0.7× 45 0.5× 43 0.5× 197 2.6× 62 465
Julia Garcia Canada 10 136 0.8× 56 0.4× 33 0.4× 108 1.3× 93 1.2× 11 327
Maria Alexiadis Australia 16 233 1.3× 26 0.2× 65 0.8× 57 0.7× 72 0.9× 26 570
Toshihide Nakada Japan 6 152 0.9× 46 0.3× 71 0.8× 35 0.4× 58 0.8× 9 370
Matteo Moretto-Zita United States 9 390 2.2× 224 1.4× 47 0.6× 55 0.7× 308 4.1× 11 636
Susanna Zanutto Italy 7 387 2.2× 81 0.5× 57 0.7× 36 0.4× 38 0.5× 13 531
Mari Ozaki Japan 10 117 0.7× 29 0.2× 66 0.8× 78 0.9× 22 0.3× 18 296
Yuanhua Ye China 14 137 0.8× 137 0.9× 34 0.4× 33 0.4× 274 3.6× 34 446
Zongsheng Yin China 11 203 1.1× 29 0.2× 21 0.3× 50 0.6× 48 0.6× 20 317

Countries citing papers authored by Julien Taurelle

Since Specialization
Citations

This map shows the geographic impact of Julien Taurelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Taurelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Taurelle more than expected).

Fields of papers citing papers by Julien Taurelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Taurelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Taurelle. The network helps show where Julien Taurelle may publish in the future.

Co-authorship network of co-authors of Julien Taurelle

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Taurelle. A scholar is included among the top collaborators of Julien Taurelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Taurelle. Julien Taurelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Brion, Régis, Kévin Biteau, Julien Taurelle, et al.. (2022). TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment. Cancers. 14(22). 5627–5627. 2 indexed citations
2.
David, Emmanuelle, Sébastien Cagnol, Julien Taurelle, et al.. (2019). 12b80 – Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma. Bioconjugate Chemistry. 30(6). 1665–1676. 19 indexed citations
4.
Biteau, Kévin, Romain Guiho, Mathias Chatelais, et al.. (2016). L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.. PubMed. 6(3). 677–89. 27 indexed citations
5.
Guiho, Romain, Kévin Biteau, Giulia Grisendi, et al.. (2016). TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models. International Journal of Cancer. 139(12). 2802–2811. 29 indexed citations
6.
Lamora, Audrey, Julie Talbot, Gwenola Bougras, et al.. (2014). Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma. Clinical Cancer Research. 20(19). 5097–5112. 90 indexed citations
7.
Rédiní, Françoise, Kévin Biteau, Julien Taurelle, et al.. (2014). Preclinical evidence of positive effect of l-MTP-PE alone or combined with zoledronic acid in osteosarcoma.. Journal of Clinical Oncology. 32(15_suppl). 10048–10048. 1 indexed citations
8.
Chesneau, Julie, Julien Taurelle, F. Gouin, et al.. (2013). A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis. European Journal of Cancer. 49(9). 2253–2263. 15 indexed citations
9.
Gallou‐Kabani, Catherine, Anne Gabory, Jörg Tost, et al.. (2010). Sex- and Diet-Specific Changes of Imprinted Gene Expression and DNA Methylation in Mouse Placenta under a High-Fat Diet. PLoS ONE. 5(12). e14398–e14398. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026